Crossmark

SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma

Crossref DOI link: https://doi.org/10.1186/s12885-018-5119-6

Published Online: 2018-12-11

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chen, Yibing

Zhao, Jingjing

Jiao, Zhihui

Wang, Weiwei

Wang, Dandan

Yu, Xiaohe

Shi, Zhiyong

Ge, Naijian

Pan, Qiuzhong

Xia, Jianchuan

Niu, Wancheng

Zhao, Ruihua

Zhang, Xiaofei

Du, Wei
Funding

Funding for this research was provided by:

National Natural Science Foundation of China ((81402560)

Henan Medical Program (201602072)

Henan Science & Technology Program (172102310271)
License Information

Text and Data Mining valid from 2018-12-01
More Information

Article History

Received: 21 August 2018

Accepted: 20 November 2018

First Online: 11 December 2018

Ethics approval and consent to participate

: This study was approved by the Ethical Committees of the Second Military Medical University and Zhegnzhou University, and written informed consent was obtained from all participants. All study procedures were carried out in accordance with the ethical standards of the Helsinki Declaration.

: Not applicable.

: The authors declare that they have no conflicts of interest.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.